Literature DB >> 6713728

In vitro immunoglobulin secretion by normal human gastrointestinal mucosal tissues, and alterations in patients with inflammatory bowel disease.

V A Danis, A D Harries, R V Heatley.   

Abstract

Intestinal mucosal immunoglobulin secretion in vitro has been studied by culture of endoscopic biopsy tissues obtained from various sites along the gastrointestinal tract. IgA and IgM were the predominant immunoglobulins produced by intestinal tissues distal to the stomach and secretion of both reached a maximum in the small intestine of normal individuals. In patients with inflammatory bowel disease, characteristic alterations in immunoglobulin production were observed in cultures of large intestinal tissue. In ulcerative colitis (UC), significant reductions in IgA secretion (P less than 0.03) occurred in the rectum during remission and IgM in the colon in active disease (P less than 0.01). However, in active Crohn's disease (CD), rectal IgM secretion was enhanced (P less than 0.004) and IgA diminished (P less than 0.01). IgG secretion was increased throughout the colon in UC especially in distal sites, due largely to significant increases in pre-formed immunoglobulin (P less than 0.02). Similar total increases were observed in colonic tissues from patients with CD, although IgG synthesis in biopsies from rectal sites was normal. These findings suggest that specific abnormalities of intestinal mucosal immunoglobulin synthesis occur in patients with both UC and CD.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6713728      PMCID: PMC1535966     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  The distribution of mucosal antibodies in the bowel of patients with Crohn's disease.

Authors:  F H Green; H Fox
Journal:  Gut       Date:  1975-02       Impact factor: 23.059

2.  Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon.

Authors:  K Baklien; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

3.  Oral manifestations of Crohn's disease.

Authors:  P Asquith; R A Thompson; W T Cooke
Journal:  Gut       Date:  1975-04       Impact factor: 23.059

4.  Intestinal immunoglobulins in ulcerative colitis.

Authors:  J Söltoft; V Binder; E Gudmand-Höyer
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

5.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

6.  The distribution of immunoglobulin-containing cells along the human gastrointestinal tract.

Authors:  P A Crabbé; J F Heremans
Journal:  Gastroenterology       Date:  1966-09       Impact factor: 22.682

7.  Rectal immunoglobulin synthesis in ulcerative colitis.

Authors:  F Aiuti; J A Garofalo
Journal:  N Engl J Med       Date:  1972-11-30       Impact factor: 91.245

8.  Immunoglobulin E in rectal mucosa of patients with proctitis.

Authors:  R V Heatley; B J Calcraft; R Fifield; J Rhodes; R H Whitehead; R G Newcombe
Journal:  Lancet       Date:  1975-11-22       Impact factor: 79.321

9.  Immunoglobulin-containing cells in the intestinal mucosa and immunoglobulins in the intestinal juice in children.

Authors:  E Savilahti
Journal:  Clin Exp Immunol       Date:  1972-07       Impact factor: 4.330

10.  The plasma cells in inflammatory disease of the colon: a quantitative study.

Authors:  J M Skinner; R Whitehead
Journal:  J Clin Pathol       Date:  1974-08       Impact factor: 3.411

View more
  13 in total

1.  Immunological study of histologically non-involved jejunum during Crohn's disease: evidence for reduced in vivo secretion of secretory IgA.

Authors:  P Marteau; J F Colombel; J Nemeth; J P Vaerman; J C Dive; J C Rambaud
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

2.  Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.

Authors:  J Rüthlein; M Ibe; W Burghardt; J Mössner; I O Auer
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

3.  Colonic mucosal T lymphocytes in ulcerative colitis: expression of CD7 antigen in relation to MHC class II (HLA-D) antigens.

Authors:  L K Trejdosiewicz; S Badr-el-Din; C J Smart; G Malizia; D J Oakes; R V Heatley; M S Losowsky
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

4.  Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: differences between ulcerative colitis, Crohn's disease, and controls.

Authors:  M G Scott; M H Nahm; K Macke; G S Nash; M J Bertovich; R P MacDermott
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

5.  Disordered regulation of the in vitro immunoglobulin synthesis by intestinal mononuclear cells in Crohn's disease.

Authors:  H W Verspaget; A S Peña; I T Weterman; C B Lamers
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

6.  Local IgA subclass alterations in ulcerative colitis and Crohn's disease of the colon.

Authors:  K Kett; P Brandtzaeg
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

7.  T lymphocytes of the human colonic mucosa: functional and phenotypic analysis.

Authors:  C J Smart; L K Trejdosiewicz; S Badr-el-Din; R V Heatley
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

8.  Interferon-gamma and tumour necrosis factor production in patients with Helicobacter pylori infection.

Authors:  X J Fan; A Chua; M A O'Connell; D Kelleher; P W Keeling
Journal:  Ir J Med Sci       Date:  1993-10       Impact factor: 1.568

9.  Local immunity in ulcerative colitis: evidence for defective secretory IgA production.

Authors:  S Badr-el-Din; L K Trejdosiewicz; R V Heatley; M S Losowsky
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

10.  Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis.

Authors:  J E Crabtree; T M Shallcross; R V Heatley; J I Wyatt
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.